lung cancer

Mirati's KRAS drug beats estimates in Q1, but Keytruda combo plan remains unclear
Fierce Pharma
Thu, 05/11/23 - 09:07 pm
Mirati Therapeutics
Krazati
Amgen
Lumakras
lung cancer
Scorpion snags $553M deal with Pierre Fabre for 2 preclinical lung cancer assets
Fierce Biotech
Tue, 04/4/23 - 12:23 pm
Pierre Fabre
Scorpion Therapeutics
lung cancer
Lazertinib and Tagrisso go head to head
EP Vantage
Fri, 03/24/23 - 10:01 am
AstraZeneca
lazertinib
Tagrisso
JNJ
lung cancer
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
CP WIre
Sat, 03/18/23 - 03:37 pm
Medtronic
Medtech
inflation
drug pricing
Pfizer
Novartis
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Yervoy
lung cancer
Xiidra
JNJ
executive compensation
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Sat, 03/18/23 - 03:35 pm
Medtronic
Medtech
inflation
drug pricing
Pfizer
Novartis
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Yervoy
lung cancer
Xiidra
JNJ
executive compensation
AstraZeneca says cancer drug Imfinzi improves survival chances in late-stage trial
Reuters
Thu, 03/9/23 - 11:40 am
AstraZeneca
Imfinzi
lung cancer
Tagrisso reaches OS endpoint in PhIII EGFR-mutated lung cancer trial
Endpoints
Thu, 03/9/23 - 10:00 am
AstraZeneca
lung cancer
clinical trials
Tagrisso
Merck reports two Phase 3 study misses for Keytruda
BioPharma Dive
Tue, 02/28/23 - 10:43 pm
Merck
clinical trials
Keytruda
prostate cancer
lung cancer
Novocure shares soar on positive lung cancer data
BioPharma Dive
Thu, 01/5/23 - 04:52 pm
Novocure
lung cancer
Medtech
devices
clinical trials
Despite Imfinzi fail in lung cancer trial, AZ 'encouraged' by one result: exec
Fierce Pharma
Mon, 12/19/22 - 12:29 pm
AstraZeneca
Imfinzi
lung cancer
non-small cell lung cancer
FDA Approval of Mirati Lung Cancer Drug Sets Stage for Competition With Amgen
MedCity News
Wed, 12/14/22 - 10:19 am
Amgen
Mirati Therapeutics
Krazati
Lumakras
FDA
lung cancer
Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients
Yahoo/Reuters
Tue, 12/6/22 - 10:21 am
Mirati Therapeutics
adagrasib
Merck
Keytruda
metastatic lung cancer
lung cancer
NanOlogy concludes subject enrolment in Phase IIa lung cancer trial
Clinical Trials Arena
Mon, 11/14/22 - 10:34 am
NanOlogy
clinical trials
lung cancer
microparticle paclitaxel
paclitaxel
FDA explains why it won't pull Jazz's accelerated approval despite a failed confirmatory trial
Endpoints
Wed, 10/26/22 - 10:34 am
Jazz Pharmaceuticals
FDA
metastatic small cell lung cancer
lung cancer
Zepzelca
4 Biotech Stocks With Huge Incoming Catalysts
Motley Fool
Wed, 10/12/22 - 11:03 am
FDA
Biogen
Eisai
Alzheimer's disease
Gilead Sciences
HIV
Mirati Therapeutics
lung cancer
lecanemab
lenacapavir
adagrasib
GSK hits go on pivotal TIM-3 lung cancer trial after phase 2 clears bar for advancement
Fierce Biotech
Wed, 10/5/22 - 10:49 am
GSK
lung cancer
clinical trials
cobolimab
non-small cell lung cancer
ESMO: Amgen's Lumakras confirmatory lung cancer data are here, fanning KRAS battle flames
Fierce Pharma
Sun, 09/11/22 - 11:07 pm
Amgen
lung cancer
ESMO
KRAS inhibitors
Jounce’s latest setback dampens outlook for another cancer immunotherapy target
BioPharma Dive
Tue, 08/30/22 - 06:10 pm
Jounce Therapeutics
lung cancer
cancer immunotherapy
vopratelimab
Novartis bid to repurpose rare disease drug for cancer falls short in third trial
BioPharma Dive
Mon, 08/15/22 - 10:15 am
Novartis
cancer
clinical trials
lung cancer
canakinumab
AstraZeneca pushes forward with Tagrisso combos, touting PhII data with Hutchmed drug
Endpoints
Mon, 08/8/22 - 09:54 am
AstraZeneca
Hutchmed
clinical trials
Tagrisso
savolitinib
lung cancer

Pages